The Discounted Cash Flow (DCF) valuation of Cellectis SA (ALCLS.PA) is (11.48) EUR. With the latest stock price at 2.49 EUR, the upside of Cellectis SA based on DCF is -561.8%.
Based on the latest price of 2.49 EUR and our DCF valuation, Cellectis SA (ALCLS.PA) is a sell. selling ALCLS.PA stocks now will result in a potential gain of 561.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.5% - 8.8% | 7.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (67.34) - (6.90) | (11.48) |
| Upside | -2808.9% - -377.4% | -561.8% |